Press
Datwyler in the media
13 results For “FecT” Clear filter
2024
Multi-Channel Soft Dry Electrodes for Electrocardiography Acquisition in the Ear Region
Datwyler and imec The Netherlands have published a study investigating the effectiveness of (smartlink: softpulse) soft dry electrodes for in-ear electrocardiography. This study underscores Datwyler’s commitment to advancing wearable health technologies and emphasizes the potential of SoftPulse™ electrodes in redefining in-ear biosignal monitoring.
2023
“PERFECTing” the pharma packaging selection process
Gabrielle Gehron, Scientific Support Manager at Datwyler, explains how to successfully analyze your pharma packaging needs and navigate through the packaging selection process.
2022
«PERFECTing» the package selection process
Gabrielle Gehron, Scientific Support Manager, Datwyler, explains how one can successfully analyse packaging needs and navigate through the packaging selection process
2021
How environmentally friendly are hybrid vehicles?
How environmentally friendly a hybrid vehicle is, depends on a great many variables, not least the way in which the boundaries of assessment are drawn. What is often overlooked is the fact that the effectiveness of plug-in hybrid vehicles in terms of their environmental impact depends very much on the driving and charging discipline of their users, especially in the case of large SUVs or luxury vehicles, which are common with this type of powertrain.
Quality is king: The case to put quality first in pharmaceutical packaging
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how Datwyler’s highest quality standard, FirstLine®, helps pharmaceutical companies minimize defects.
Smart goals and continuous improvement for a resilient sustainability strategy
Forecasts on the effects of climate change have prompted all industries, including the pharmaceutical sector, to implement more environmentally responsible practices.
Drug Defense: Designing Against Defects.
In times of crisis—like the current COVID-19 pandemic—there is no time or resource to waste on the issues that stem from defective or problematic drug packaging. Datwyler’s Key Account Manager, Rahul Thakar, explains how quality-by-design thinking enables drug efficacy and minimized opportunities for contamination.
2020
Drug defence: designing against defects
«Quality by Design» thinking enables drug efficacy and minimises opportunities for contamination.
Designing against defects
Datwyler’s Technical Key Account Manager, Rahul Thakar, discusses how ‘Quality-by-design’ enables drug efficacy & minimises contamination.
Drug Protection: Eliminate Defects
In OFWeek, Datwyler discusses how to set goals for zero defects in pharmaceutical packaging manufacturing and why this is a critical process consideration, especially during a pandemic.
More than halving development times is not uncommon
Simulation opens up great potential for rationalisation in component development. The automotive industry is a key driver for many developments in the sealing and polymer sector. This already has an effect during prototyping. DICHT! discussed why this is the case with Rudolf Randler, Head of Simulation, Andreas Minatti, Head of Business Development, and Konrad Dubler, Team Leader Engineering Mobility of Datwyler Switzerland Ltd.
Achieving Zero Defects in a Pandemic
When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.
«Aiming for Perfection in a Pandemic», an opinion by Datwyler
«When Lives and Livelihoods Depend on Accelerating Large Molecule Drug Production, Biopharma Companies must Minimize Defects and Contamination» says Massimo Mainetti, Global Head of Marketing and Product Management, Datwyler.